A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Irradiation
Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of the combination of the two
drugs, docetaxel (Taxotere®) and carboplatin (Paraplatin®) followed by radiation directed at
the tumor in treating your endometrial cancer.